Kidney Week

Basic/Clinical Science Session

Wrangling the RAAS in Kidney Diseases - Honoring Stephen Textor

October 26, 2024 | 02:00 PM - 04:00 PM

Location: Room 5, Convention Center

Session Description

This session provides insights into the future of novel therapies that inhibit different aspects of the RAAS for the management of hypertension in CKD and ESKD and the diagnosis and management of primary aldosteronism in CKD. This session also honors Dr. Stephen Textor who was an internationally renowned nephrologist and expert in hypertension, particularly regarding blood pressure regulation, renovascular hypertension, and atherosclerotic renal artery stenosis.

Learning Objective(s)

• Outline the mechanisms and potential benefits of novel therapies that target the RAAS
• Discuss the optimal approach to RAAS blockade in ESKD
• Describe appropriate screening and management of primary aldosteronism in patients with CKD
• Explain the connection between leptin and aldosterone signaling

Learning Pathway(s)

• Hypertension and Cardiorenal Disorders

Moderators

• James M. Luther, MD, MS, FASN
• Sandra J. Taler, MD

Presentations

• Introduction
  02:00 PM - 02:01 PM
  
  • James M. Luther, MD, MS, FASN
  • Sandra J. Taler, MD

Introduction

October 26, 2024 | 02:00 PM - 02:01 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Aldosterone Synthase Inhibition as a "New Kid on the Block" in Hypertension and CKD Treatment
  02:01 PM - 02:30 PM
  
  • M. Luiza A. Caramori, MD, MS, PhD

Aldosterone Synthase Inhibition as a "New Kid on the Block" in Hypertension and CKD Treatment

October 26, 2024 | 02:01 PM - 02:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Full Circle View of Mineralocorticoid Receptor Antagonism for Treatment of CKD and ESKD
  02:30 PM - 03:00 PM
  
  • Rajiv Agarwal, MD, MS, FASN

Full Circle View of Mineralocorticoid Receptor Antagonism for Treatment of CKD and ESKD

October 26, 2024 | 02:30 PM - 03:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Primary Aldosteronism in CKD: Are We Missing the Mark?
  03:00 PM - 03:30 PM
  
  • Debbie L. Cohen, MD, FASN

Primary Aldosteronism in CKD: Are We Missing the Mark?

October 26, 2024 | 03:00 PM - 03:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Sexually-Dimorphic Responses to Aldosterone Antagonism in Hypertensive Kidneys
  03:30 PM - 04:00 PM
  
  • Mykola Mamenko, PhD

Sexually-Dimorphic Responses to Aldosterone Antagonism in Hypertensive Kidneys

October 26, 2024 | 03:30 PM - 04:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.